FDA Approves Kanuma™ (sebelipase alfa) for the Treatment of Patients with Lysosomal Acid Lipase Deficiency (LAL-D).
![Evaluation of two approaches to lysosomal acid lipase deficiency patient identification: An observational retrospective study - ScienceDirect Evaluation of two approaches to lysosomal acid lipase deficiency patient identification: An observational retrospective study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S002191501930142X-fx1.jpg)
Evaluation of two approaches to lysosomal acid lipase deficiency patient identification: An observational retrospective study - ScienceDirect
![Therapy for lysosomal acid lipase deficiency: Replacing a missing link - Grabowski - 2013 - Hepatology - Wiley Online Library Therapy for lysosomal acid lipase deficiency: Replacing a missing link - Grabowski - 2013 - Hepatology - Wiley Online Library](https://aasldpubs.onlinelibrary.wiley.com/cms/asset/be0e393c-1adf-4ae1-90ff-057c0a67ed87/hep26366-fig-0001-m.jpg)
Therapy for lysosomal acid lipase deficiency: Replacing a missing link - Grabowski - 2013 - Hepatology - Wiley Online Library
![Lysosomal Acid Lipase Deficiency (LAL-D) ...an under-recognized inherited disease affecting both children and adults - Dr. Gish Lysosomal Acid Lipase Deficiency (LAL-D) ...an under-recognized inherited disease affecting both children and adults - Dr. Gish](https://www.robertgish.com/assets/images/blog-images/lysosomal-acid-lipase-deficiency-lal-d-an-under-recognized-inherited-disease-affecting-both-children-and-adults.png?_cchid=2450ab7e0b0ad73cf970340f8f4f2445)
Lysosomal Acid Lipase Deficiency (LAL-D) ...an under-recognized inherited disease affecting both children and adults - Dr. Gish
![Lysosomal Acid Lipase in Lipid Metabolism and Beyond | Arteriosclerosis, Thrombosis, and Vascular Biology Lysosomal Acid Lipase in Lipid Metabolism and Beyond | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/f6143a3e-f325-4d2c-8736-5ccf3d595795/850ga1.jpg)
Lysosomal Acid Lipase in Lipid Metabolism and Beyond | Arteriosclerosis, Thrombosis, and Vascular Biology
![Life Saving Drugs Program – Infantile-onset lysosomal acid-lipase deficiency disease (LAL-D) – Guidelines | Australian Government Department of Health and Aged Care Life Saving Drugs Program – Infantile-onset lysosomal acid-lipase deficiency disease (LAL-D) – Guidelines | Australian Government Department of Health and Aged Care](https://www.health.gov.au/sites/default/files/2023-03/life-saving-drugs-program-infantile-onset-lysosomal-acid-lipase-deficiency-disease-lal-d-guidelines.jpg)
Life Saving Drugs Program – Infantile-onset lysosomal acid-lipase deficiency disease (LAL-D) – Guidelines | Australian Government Department of Health and Aged Care
![Persistent dyslipidemia in treatment of lysosomal acid lipase deficiency | Orphanet Journal of Rare Diseases | Full Text Persistent dyslipidemia in treatment of lysosomal acid lipase deficiency | Orphanet Journal of Rare Diseases | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13023-020-1328-6/MediaObjects/13023_2020_1328_Fig2_HTML.png)
Persistent dyslipidemia in treatment of lysosomal acid lipase deficiency | Orphanet Journal of Rare Diseases | Full Text
![Life Saving Drugs Program – Infantile-onset lysosomal acid-lipase deficiency disease (LAL-D) – Initial application | Australian Government Department of Health and Aged Care Life Saving Drugs Program – Infantile-onset lysosomal acid-lipase deficiency disease (LAL-D) – Initial application | Australian Government Department of Health and Aged Care](https://www.health.gov.au/sites/default/files/styles/h_content_max_width_no_upscale/public/2023-03/life-saving-drugs-program-infantile-onset-lysosomal-acid-lipase-deficiency-disease-lal-d-initial-application.jpg?itok=Yen756dm)
Life Saving Drugs Program – Infantile-onset lysosomal acid-lipase deficiency disease (LAL-D) – Initial application | Australian Government Department of Health and Aged Care
![Acid Lipase Deficiency Market – Global Industry Trends and Forecast to 2029 | Data Bridge Market Research Acid Lipase Deficiency Market – Global Industry Trends and Forecast to 2029 | Data Bridge Market Research](https://www.databridgemarketresearch.com/media/2022/2/GlobalAcidLipaseDeficiencyMarket.jpg)
Acid Lipase Deficiency Market – Global Industry Trends and Forecast to 2029 | Data Bridge Market Research
![Lysosomal Acid Lipase: From Cellular Lipid Handler to Immunometabolic Target: Trends in Pharmacological Sciences Lysosomal Acid Lipase: From Cellular Lipid Handler to Immunometabolic Target: Trends in Pharmacological Sciences](https://www.cell.com/cms/attachment/8562298e-c447-4a03-b6cc-bbc3e4b7bb28/gr1_lrg.jpg)